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Abstract Tissue engineering of bone and oral mucosa
have been extensively studied independently. The aim of this
study was to develop and investigate a novel combination of
bone and oral mucosa in a single 3D in vitro composite tissue
mimicking the natural structure of alveolar bone with an
overlying oral mucosa. Rat osteosarcoma (ROS) cells were
seeded into a hydroxyapatite/tri-calcium phosphate scaffold
and bone constructs were cultured in a spinner bioreactor for
3 months. An engineered oral mucosa was fabricated by air/
liquid interface culture of immortalized OKF6/TERET-2
oral keratinocytes on collagen gel-embedded fibroblasts.
EOM was incorporated into the engineered bone using a
tissue adhesive and further cultured prior to qualitative and
quantitative assessments. Presto Blue assay revealed that
ROS cells remained vital throughout the experiment. The
histological and scanning electron microscope examinations
showed that the cells proliferated and densely populated the
scaffold construct.Micro computed tomography (micro-CT)
scanning revealed an increase in closed porosity and a
decrease in open and total porosity at the end of the culture
period.Histological examination of bone-oralmucosamodel
showed a relatively differentiated parakeratinized epithe-
lium, evenly distributed fibroblasts in the connective tissue
layer and widely spread ROS cells within the bone scaffold.
The feasibility of fabricating a novel bone-oral mucosa
model using cell lines is demonstrated. Generating human
‘normal’ cell-based models with further characterization is
required to optimize the model for in vitro and in vivo
applications.
1 Introduction
Composite tissue engineering (TE) constitutes a new ave-
nue particularly in the oral and maxillofacial area where a
variety of tissues are closely associated to each other. This
proximity often results in the loss of multiple tissue types
complicating reconstruction of disfiguring developmental,
pathological, or traumatic defects.
Bone loss is a commonly encountered problem that can
range from small periodontal defects to more complex,
difficult to manage structural defects. Data from National
Health and Nutrition Examination Survey (NHNES)
showed a high incidence of periodontitis in the US affecting
approximately half of the population aged C30 years with
8.9 % having sever periodontitis that warrant surgery [1]. A
recent multicentre trauma (EURMAT) research which was
carried out across several European Oral Surgery centres
showed an increasing incidence of maxillofacial trauma
resulting in bone loss [2].
Bone loss is conventionally managed by autologous
bone grafting. This approach is associated with drawbacks
such as co-morbidity of the donor site, limited availability
at donor sites, extended surgical time and hospital stays,
high incidence of post-operative complications, non-union
which may be as high as 69 % [3] and unpredictable bone
resorption of up to 50 % of the initial volume [4]. Allo-
grafts or xenografts are available, low cost alternatives, but
there are ethical/religious issues and concerns with the risk
of disease transmission although the overall risk is very
low [3]. Osteoconductive synthetic materials are another
potential option but their use is limited by the inappropriate
mechanical properties, high and unpredictable resorption
rates and their lack of osteogenic potential [5].
Soft tissue defects in isolation can be reconstructed by
grafting either from oral mucosa or split-thickness skin.
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However, both are associated with high donor site mor-
bidity. In addition, oral mucosa graft is limited in supply
whereas vascularized skin flap contains skin appendages,
expresses different keratinization pattern, is easily infected
in wet oral environment [6] and heals with scar formation
[7]. For composite oral and maxillofacial tissue recon-
struction, microvascular free tissue transfer such as osteo-
cutanous radial forearm flap has been widely embraced.
Nevertheless, it is associated with significant morbidity
including hand ischemia, radius fracture, neurological
injuries, and graft failure functionally and aesthetically [8].
TEhas offered anopportunity to bypass these shortcomings
through many strategies aiming to emulate the normal tissue
anatomically and physiologically. Bone engineering with the
remarkable advances in biomaterials, scaffold fabrication,
stem cell therapy, and molecular biology may provide a
potential solution for oro-facial reconstruction [9]. Similarly,
an EOM has been developed, characterized, and used for
various intra and extra oral applications [10, 11] with the
feasibility of a reproducible ex vivo fabrication for treatment
of various congenital and acquired intraoral defects [12–14].
Although the progress in TE seems promising, the
clinical use is still limited. The experimental applications,
on the other hand, provide unique opportunities to inves-
tigate the interactions among cells, matrix, biomolecules,
and environmental factors that cannot be otherwise studied
[15]. In addition, in vitro human constructs may minimize
the need for lengthy, costly, and controversial animal
studies which can be misleading due to interspecies
molecular and physiological differences [16].
While EB and EOM as single separate tissues have
received significant attention, only few studies have
focused on bone or soft tissue as a part of compound
construct [17, 18]. The aim of this study was to develop an
in vitro TE composite bone/oral mucosal model mimicking
the natural structure of alveolar bone with an overlying oral
mucosa. This study has not been previously undertaken and
we are the first group to report the development of an
in vitro 3D full-thickness osteo-mucosal model containing
tissue engineered bone and oral mucosa.
2 Materials and methods
2.1 Materials
All materials were purchased from Sigma, UK unless
otherwise stated.
2.2 Cell culture conditions
Rat osteosarcoma-derived cell line (ROS) was obtained
from liquid nitrogen storage in the School of Clinical
Dentistry, University of Sheffield. The cells were cultured
in a high glucose complete Dulbecco’s Modified Eagles
Medium (CDMEM) supplemented with 10 % v/v foetal
bovine serum, 2 mM L-glutamine, 100 U:100 lg ml-1
Penicillin–Streptomycin, 625 ng ml-1 amphotericin. An
immortalized human oral epithelial cell line (OKF6-
TERET-2) was kindly provided by Brigham and Women’s
Hospital, Harvard Institute of Medicine, USA. The cells
were cultured in Green’s medium which consisted of
Dulbecco’s Modified Eagle’s medium and Hams F12
medium (Gibco, USA) in a 3:1 ratio supplemented with
10 % foetal bovine serum, 2 mM glutamine, 100
U:100 lg ml-1 penicillin–streptomycin, 2.5 lg ml-1
amphotericin B, 10-4 M adenine, 5 lg ml-1 insulin,
2 9 10-7 M l-1 triiodothyronine, 5 lg ml-1 transferrin,
0.4 lg ml-1 hydrocortisone, 10 ng ml-1 Epidermal
growth factor (Invitrogen, USA). Normal oral fibroblasts
(NOF) were isolated from keratinized gingival biopsies as
previously described [19]. Briefly, biopsies were obtained
with written, informed consent from patients attending
Charles Clifford Dental Hospital, Sheffield, under ethical
approval from National Research Ethics Committee Lon-
don-Hampstead. The epithelium and dermal layers were
enzymatically separated by incubating the tissues in trypsin
1:250 in PBS for 1 h at 4 C then 2 h at 37 C. The
epithelial layer was scraped and the connective tissue layer
of the oral mucosa biopsy was incubated in 0.05 % (w/v)
collagenase type I solution (Gibco, USA) in CDMEM at
37 C overnight. Digested tissue was centrifuge at 200 rpm
for 5 min and the pellet was re-suspended in CDMEM and
cultured in T-75 cell culture flask.
All cell types were incubated in a humidified atmo-
sphere at 37 C and 5 % CO2/95 % air. The medium was
changed 3 times a week until the cells were 90 % confluent
when they were sub-cultured while NOFs were passaged
up to 2 times.
2.3 Engineered bone model (EB)
9 sterile ceramic discs (3 mm 9 20 mm) of Hydroxyap-
atite/Tricalcium phosphate (HA/TCP) (60 %/40 %) (Cer-
amisys LTD, UK) with a pore diameter range of
200-450 lm were used as scaffold. Six discs were sus-
pended in a spinner bioreactor (Branstead Stem, UK) to be
seeded by cells. 50 ll of ROS cell suspension having a cell
density of 2x106 cells were added dropwise to each disc.
The cells were allowed to adhere for 2 h and then the cell/
scaffold constructs were completely covered with 100 ml
of CDMEM and left in the incubator overnight. The spin-
ner was generated after 24 h at a rotation speed of 30 rpm
and the medium was changed every 2–3 days for three
months. The remaining 3 discs were used as negative
control (acellular).
 65 Page 2 of 8 J Mater Sci: Mater Med  (2016) 27:65 
123
2.4 Engineered oral mucosal model (EOM)
Rat-tail type I collagen was isolated from the tails of Wistar
rats as previously described [20]. The extracted collagen was
dissolved in 0.1 M acetic acid, freeze dried, and re-dissolved
in 0.1 M acetic acid to a stock concentration of 5 mg ml-1
and stored at 4 C. 20 days prior to the end of EB culture,
collagen-based EOM was constructed according to the
technique described by Dongari-Bagtzoglou [21]. Keeping
everything on ice, a solution of DMEM 13.8 mg ml-1, FCS
8.5 % (v/v), L-glutamine 2 mM, reconstitution buffer
(22 mg ml-1 sodium bicarbonate and 20 mM HEPES in
0.062 N NaOH), and 5 mg ml-1 rat-tail type I collagen was
prepared and neutralized to pH 7.4 by addition of 1 M
sodium hydroxide. Finally, cell suspension of primary
fibroblasts at a concentration of 1 9 106/model in CDMEM
was added to the solution and the resultant fibroblast-con-
taining suspension was distributed into tissue culture inserts
(0.4 lm pore size, 30 mm diameter, Millipore) and incu-
bated at 37 C for 2 h until solidified. Then, 1.5 ml of
CDMEM was added inside and outside the insert. The gel
was cultured for 3 days until it contracted. Following con-
traction, 1 9 106 of OKF6/TERT-2 suspended in 50 ll of
Green’s medium were seeded on the gel surface and allowed
to adhere for 2 h. Subsequently, 2 ml of Green’s medium
was gently added into the insert and incubated at 37 C, 5 %
CO2 for 3 days. When epithelial cells reached confluency,
the culture was raised to the air/liquid interface and fed
every other day for 12–14 days.
2.5 Engineered bone-oral mucosa model
Once the culture of the EB and EOM was completed, both
were combined using a biocompatible fibrin-based adhe-
sive sealant (ARTISS, Baxter, UK). Briefly, the EBM was
retrieved from the spinner flask and placed on a sterile
culture plate containing 10 ml of CDMEM. Fibrin was
defrosted, the components in pre-filled syringe were mixed,
and only a thin layer of the mixed Protein–Thrombin sealer
was applied on the dermal side of EOM. Then the latter
was immediately attached to the surface of EB and held in
the desired position with gentle compression for at least
3 min to ensure ARTISS sets completely and both models
were firmly adhered. The bone-oral mucosa construct was
further cultured at air/liquid interface for 5 days after
which the model was fixed for histological examination.
2.6 Assessments
At the end of each month, the EB models were assessed by;
PrestoBlue (PB) vitality assay, histological, and scanning
electron microscopy (SEM) examinations. In addition,
Micro-computed tomography (micro CT- scan) was used to
image the EB at the end of the culture period. Histological
examination, SEM, and CT scanning were also carried out
for the control discs (acellular).
2.6.1 PB assay
PB viability assay (Invitrogen, USA) was used to monitor
the cell viability throughout the study. Away from direct
light, the old medium in the spinner was aspirated, the
seeded discs were washed with PBS and 100 ml of new
CDMEM was added. Then, a 1/10th volume of PB reagent
was added directly into the spinner and incubated for
C10 min. Quadruplicate samples of 200 ll were taken and
read after incubation for 180 min using spectrophotometric
plate reader (Infinite M200, TECAN, USA). Cell viability
was detected with fluorescence (560 nm excitation and
590 nm emission) and the mean values were calculated
separately for four independent experiments.
2.6.2 Histological examination
EB models were retrieved, fixed in 10 % (v/v) PBS-buffered
formalin for 24 h, and decalcified with formic acid for the
same period. Specimens were processed overnight using a
bench top tissue processor (Shandon Citadel 2000, Thermo
Scientific, UK) and embedded in paraffin wax using a Leica
EG1160 embedding centre (Leica Microsystems). Then,
10 lm sections were prepared, stained with haematoxylin
and eosin (H&E), and examined using inverted microscope
equipped with a digital camera (Olympus, Japan).
2.6.3 SEM
EB models were rinsed with 5 ml of 0.1 cacodylate buffer,
fixed with 3 % of gluteraldehyde for 3 h, and then rinsed
again with cacodylate buffer. Osmium tetroxide was added
to cover the material surface and left for 2 h. Then, the
samples were washed with buffer and dehydrated gradually
with the increasing concentration of ethanol solutions (75,
95, and 100 %) for 15 min each. The samples were air
dried overnight, then mounted onto 20 mm diameter stubs
and their surfaces were sprayed with gold (*20 nm). Cell
attachment, adhesion, distribution, and secretion were
observed using the SEM (Philips XL-20, USA).
2.6.4 Micro-CT
The characteristics of the HA-TCP scaffold and the EB at
the end of the experiment were assessed by a high reso-
lution micro-CT scanner (SkyScan 1172; Bruker, Bel-
gium). The sample was covered by polystyrene and
positioned horizontally on a brass holder in the centre of
the specimen stage. Cross-sectional images were
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PB assay revealed that ROS cells remained vital through-
out the experiment with fluorescence emission mean val-
ues: 39,136.75 ± 2310.47, 26,140 ± 73.66,
38,567 ± 1681.18, 22,560.25 ± 2561.11 at baseline, 1st,
2nd and 3rd month respectively. The readings showed a
slight decline in the cellular metabolic activity after
1 month culture and the end of the 3rd month. PB is con-
sidered the fastest resazurin-based assay that gives an
accurate reading with short incubation period (10 min to
2 h). In our experiments, however, the optimal readings
were obtained after approximately 3 h dye incubation for
the colour to turn pink indicating persistent cellular vitality.
3.2 Histological examination
The histological observation of the EB revealed dense
concentration of the cells and even distribution in the 1st
month. There was a gradual decrease in density of the cells
in the 2nd and 3rd months (Fig. 1a–d).
Engineered bone-oral mucosa construct (Fig. 2a), on the
other hand, showed a relatively differentiated parakera-
tinized epithelial tissue with 7-9 cell layers of OKF6/TRET-
2 (Fig. 2b). Fibroblasts were evenly distributed in the con-
nective tissue layer and bone-oral mucosa interface showed
a thin band of fibrin sealant adhering the soft and hard tis-
sues. ROS cells were populated underneath the sealant and
scattered around the remaining matrix (Fig. 2c, d).
3.3 SEM examination
In the 1st month, the surface characteristics of the EB
demonstrated the adherent cells proliferated and arranged in
dense aggregates or clusters covering the entire scaffold sur-
face and filling the pores. The growing cells had rather a
plump, rounded morphology with a thin layer of secreted
matrix appearing in few areas (Fig. 3b). In the 2nd and 3rd
month, however, the cells revealed a shrunk degenerative
appearance at the surface. Some areas were devoid of cells
whereas in other areas a calcified matrix and mineral depo-
sition occluding the scaffold pores were observed (Fig. 3c, d).
3.4 Micro CT-scan assessment
A micro-CT was used to analyse the characteristics of
acellular HA-TCP scaffold (control) and compare it with
the EB at the end of culture (experimental). After three
Fig. 1 Histological sections of a acellular HA/TCP scaffold; b EB after one month culture; c EB after 2 months culture; and d EB at the end of
three months culture. H&E staining, original magnification 920
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months of dynamic culture in spinner flask, the quantitative
3D analysis of EB revealed a marked increase in closed
porosity (volume, percentage, number and surface) and
surface density while total and open porosity showed
decrease in percentage (Table 1).
4 Discussion
In the oral cavity, periosteum and bone are directly
attached to the overlying oral mucosa without intervening
tissues such as muscle or facia. Success in the fabrication
of an in vitro model incorporating hard and soft tissues in
one unit will be valuable in investigating the association
between these entities instead of examining each tissue
individually. In the present work, an in vitro composite
construct was developed to mimic oral bone-mucosa
structure.
This study demonstrated that improving the quality of
culture environment by using spinner bioreactor provided a
dynamic microenvironment within the interconnected
pores which enhanced nutrient necessary for cells cultiva-
tion. This finding is in agreement with many previous
studies showing that spinner flask could mitigate the mass
transport limitation and promote cells proliferation, dif-
ferentiation, and expression of osteogenic markers [22, 23].
In addition, the cellular trend observed in ROS/HA-TCP
construct was in some way consistent with normal osteo-
blasts’ growth sequence which consists of three principle
periods. First; strong proliferation with ECM formation,
second; down- regulation of proliferation accompanied by
matrix maturation and up regulation of alkaline phos-
phatase (ALP) expression, and third; mineralization phase
with further decline in proliferation and ALP activity [24].
Similar observations in this study is presumably because
ROS cells possess a typical osteoblastic phenotype and
responses analogous to those of normal bone cells [25, 26].
The micro-CT analysis which is used to accurately and
efficiently segment and characterize the internal structure
of bone and bone replacement materials [27, 28] confirmed
the data obtained from histological examinations. It may
indicate the cell-mediated dissolution processes within the
Fig. 2 Histological sections of the engineered a bone-oral mucosa model; b epithelium; c connective tissue; and d hard tissue layers. H&E
staining, original magnification 910, 960, 920, 920 respectively
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HA-TCP scaffold which resulted in significant increase of
percentage, number, and volume of closed pores within the
scaffold and increase in the density of the EB.
Although cellular vitality persisted in vitro for a rela-
tively long period (3 months), our qualitative and quanti-
tative investigations revealed a marked decrease in
cellularity over time which may indicate necrotic cell
death. This may be attributed to the limitation of the
spinner bioreactor as it promotes the external mass trans-
port and ECM production at the construct surface, while
the dominant nutrient exchange within the construct
remains by diffusion [29]. Furthermore, ROS cancer cells
have higher proliferation rate and nutritional demand than
normal primary osteoblasts which can result in early
deprivation from nutrients and cell death which was
noticed in this study towards the 2nd and the 3rd months of
the culture.
Scaffold size and culture time are other contributing
factors that can compromise cell viability. A comprehen-
sive review carried out by Martina and Giuseppe Maria De
[30] demonstrated that small size cellular scaffold and/or
short in vitro culture period for 14–30 days were pre-
dominantly utilized in those studies referred to the advan-
tage of spinner in BE. Meinel et al. [31] cultured human
mesenchymal stem cells (MSCs) on 11 mm 9 1.5 mm
collagen scaffold for 5 weeks. They showed that in spite of
porosity and minimal thickness of scaffold, spinner culture
did not adequately support mass transport. The penetration
depth appeared to be 1 mm or less resulting in bone for-
mation in the exterior and cell death in the centre. Simi-
larly, Zhang et al. [32] compared spinner, perfusion,
rotating wall, and biaxial bioreactors for their application
in BE and concluded that only the latter achieved high
cellularity in large 785 mm3 scaffolds.
Long culture periods may further hinder the nutrition by
secretion of ECM components such as proteins and pro-
teoglycans which are relatively macromolecules with low
Fig. 3 Scanning electron micrographs of a acellular HA-TCP scaffold; b cell growth within the bone construct in the 1st month; c deposition of
some calcified nodules in the 2nd month; and d mineral deposition and pores closure in the 3rd month
Table 1 Micro-CT scan analysis of the HA/TCP scaffold and EB at
the end of 3 months culture period
Scaffold EB
Closed porosity % 0.02 0.06
Volume of closed pores (mm3) 0.04 0.17
Bone surface density (1/mm) 15.56 20.16
Surface of closed pores (mm2) 9.08 31.65
Open porosity % 67.38 55.33
Total porosity % 67.39 55.36
Volume of open pore space (mm3) 422.53 326.81
Total volume of pore space (mm3) 422.57 326.98
Connectivity density (1/mm3) 390.18 784.66
Number of closed pores 4959.00 11,587.00
Connectivity 244,651.00 463,434.00
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diffusion coefficients [33]. Consequently, cells become
enclosed by the matrix occluding the open pores as shown
in this study.
The morphological features and formation of osteoid-
like structures observed in this in vitro model which is based
on rat osteosarcoma cell line, are consistent with the gen-
erally accepted fact that malignant cells express the dif-
ferentiated features of the tissue of origin but do not
represent the functional properties in terms of cellular
products and response which are often species specific [34].
In respect to EOM, and in the process of reproducing
and standardizing, normal oral epithelial cell line immor-
talized by forced expression of telomerase (OKF6/TERT-
2) was used instead of normal oral keratinocytes. These
cells retain their growth control and differentiation poten-
tial in culture as telomerase expression rescues cells from
the mechanism of senescence without affecting the major
growth behaviour [35]. Underlying connective tissue
fibroblasts cultured in this model can proliferate and pro-
duce ECM which provide a condition for keratinocytes
proliferation and differentiation better than any artificial
matrix [36].
One would speculate that an alternative method of
generating bone-oral mucosa model would be growing the
soft tissue component directly over a piece of bone.
However, this may be technically infeasible due to the lack
of universal media formulations that would be suitable for
different types of cells in a single culture. In addition, this
technique may raise the question of how long the cells,
particularly in the air lifted epithelium, can survive in the
presence of bone that may prevent adequate delivery of
medium that is not directly contacted the oral mucosa
substitute [18]. Although our composite model revealed
that epithelial cells survived for an additional 5 days after
final assembly of the full-thickness model in vitro, it must
be emphasized that this finding should be interpreted with
caution as it does not necessarily represent human primary
cells. Further investigations are underway to compare the
quality and differentiation status of our newly developed
composite tissue model with those of an osteo-mucosal
model reconstructed using primary human oral ker-
atinocytes and fibroblasts and normal human alveolar
bone-derived osteoblasts.
5 Conclusions
The present work indicates that in vitro engineering of
bone-oral mucosa model which histologically resembles
native human alveolar bone and oral mucosa complex
could be established. Combined HA/TCP scaffold seems to
be a suitable scaffold for bone engineering although cell
vitality can be compromised using ROS cells with high
metabolic demand over extended and long culture periods
beyond 1 month. The use of fibroblast-populated collagen
gel for oral mucosa assembly and employing a biocom-
patible fibrin-based adhesive to combine the reconstructed
soft and hard tissues appear to be successful approaches in
TE of a composite osteo-mucosal system. The current
findings will ultimately serve as primitive proof of the
concept to fabricate an optimised and well- characterised
model.
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